(Press-News.org) Researchers at McGill University have come up with an innovative approach to improve the energy efficiency of carbon conversion, using waste material from pulp and paper production. The technique they’ve pioneered using the Canadian Light Source at the University of Saskatchewan not only reduces the energy required to convert carbon into useful products, but also reduces overall waste in the environment.
“We are one of the first groups to combine biomass recycling or utilization with CO2 capture,” said Ali Seifitokaldani, Assistant Professor in the Department of Chemical Engineering and Canada Research Chair (Tier II) in Electrocatalysis for Renewable Energy Production and Conversion. The research team, from McGill’s Electrocatalysis Lab, published their findings in the journal RSC Sustainability.
Capturing carbon emissions is one of the most exciting emerging tools to fight climate change. The biggest challenge is figuring out what to do with the carbon once the emissions have been removed, especially since capturing CO2 can be expensive. The next hurdle is that transforming CO2 into useful products takes energy. Researchers want to make the conversion process as efficient and profitable as possible.
About the study
Efficient integration of carbon dioxide reduction and 5-hydroxymethylfurfural oxidation at high current density was published in RSC Sustainability (2024).
END
Using pulp and paper waste to scrub carbon from emissions
2024-04-08
ELSE PRESS RELEASES FROM THIS DATE:
First-in-human study demonstrates reduction of hard-to-reach ventricular tachycardias
2024-04-08
Berlin, Germany – 8 April 2024: A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).1
VT is a leading cause of sudden death in patients with heart failure and a reduced ejection fraction.2 Approximately 30% of patients with ischaemic and non-ischaemic cardiomyopathies develop ventricular arrhythmias including VT.3 Typical therapies to prevent VT include antiarrhythmic medication, such as amiodarone, and an implantable ...
McMaster researchers create first-ever guidelines to help kids build tolerance to food allergens
2024-04-08
Researchers with McMaster University have crafted the first-ever guidelines to help prepare families who plan to build their child’s tolerance to common food allergens.
These international guidelines, published on April 8, 2024 in the Journal of Allergy and Clinical Immunology, standardize the preparation process for families considering oral immunotherapy, a process that involves giving very small amounts of an allergen, like peanuts, to patients and gradually increasing the amount to build up their tolerance.
Until now, ...
International experts agree on standards for catheter ablation of atrial fibrillation
2024-04-08
Berlin, Germany – 8 April 2024: An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation is published today in EP Europace,1 a journal of the European Society of Cardiology (ESC), and presented at EHRA 2024, a scientific congress of the ESC.2
Lead author Dr. Stylianos Tzeis said: “Ablation is the most effective way to prevent recurrences of atrial fibrillation and delay progression to more advanced forms. Pioneering techniques have emerged since the previous consensus in 2017,3 requiring new advice on who should receive this procedure and how to perform it in the safest and most effective manner.”
Atrial ...
Virtual reality sessions lessen cancer pain in clinical trial
2024-04-08
A 10-minute virtual reality (VR) session significantly lessened pain in hospitalized patients with cancer in a recent clinical trial published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Even a day later, participants experienced sustained benefits.
Most people with cancer experience pain, and treatment usually involves medications including opioids. VR sessions that immerse the user in new environments have been shown to be a noninvasive and nonpharmacologic way to lessen pain in different patient populations, but data are lacking in individuals ...
Cannabis use during pregnancy linked to increased risk of ADHD, autism and intellectual disability in children
2024-04-08
A new study presented at the European Psychiatric Association Congress 2024 reveals a significant association between prenatal cannabis use disorder (CUD) and an increased risk of neurodevelopmental disorders in offspring, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability (ID).
Cannabis remains by far the most consumed illicit drug in Europe. Around 1.3% of adults in the European Union (3.7 million people) are estimated to be ...
New study highlights the link between depression and breast cancer mortality in women
2024-04-08
A new study presented at the European Psychiatric Association Congress 2024 sheds light on the significant impact of depression on the survival rates and quality of life for women diagnosed with breast cancer. This study, conducted by a team of researchers in Russia, conducted a comprehensive analysis of existing research on the prevalence and impact of depression in breast cancer patients.
Breast cancer is the most common cancer among women and a leading cause of death globally and in the EU, it is estimated that 1 in 11 women in the EU-27 will develop breast cancer ...
Key to unlocking the secret of degenerative brain disorders found
2024-04-08
Alzheimer's disease and Parkinson's disease, along with stroke, are among the top three neurodegenerative disorders, characterized by the malfunction and progressive degeneration of neurons, the nerve cells. Understanding the mechanisms underlying these neurological disorders and developing therapies requires labeling technologies that can visualize neuronal changes not only in normal conditions but also in disease states.
A research team led by Dr. Kim Yun Kyung from the Brain Science Institute at the Korea Institute of Science and Technology (KIST), in collaboration with Professor Chang Young-Tae's team from Pohang University of Science ...
Understanding the link between family physician characteristics and COVID-19 vaccination gaps
2024-04-08
New research examining the characteristics of physicians with the largest share of patients unvaccinated against SARS-CoV-2 may help increase vaccination rates going forward. The study, published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230816, found that family physicians in Ontario with the largest percentage of unvaccinated patients generally served patients living in marginalized neighbourhoods and had less support in their practices.
Researchers analyzed linked data on 9060 family physicians with more than 10 million enrolled patients ...
Ontario’s proposed plan to broaden alcohol sales will harm people
2024-04-08
The Ontario government’s plans to broaden alcohol sales to privately operated stores in the province could lead to higher consumption rates and related harms, write commentary authors in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240069.
“These changes will result in a 289% increase in the number of alcohol stores in Ontario (n = 2935 in March 2023, per the Liquor Control Board of Ontario), will likely reduce the price of alcohol, and will represent the biggest shift in decades with respect to how alcohol is sold in Canada,” write Drs. Norman Giesbrecht, Centre for Addiction and ...
Researchers identify an economic solution to Canada's opioid crisis
2024-04-08
Nasal-administered naloxone is more cost-effective and could help reduce the number of opioid-related fatalities compared to the current publicly funded intermuscular version, a new study has found.
Since 2016, Canada's opioid crisis has worsened, with over 40,000 opioid-related deaths, or about 22 deaths per day. Most of these accidental deaths (88 per cent) occur in British Columbia, Alberta and Ontario.
An effective way to help prevent opioid-related deaths is through community pharmacy-based naloxone programs. Currently, ...